PHILADELPHIA, PA — Ethos Cannabis has launched Huny Ratio Troches, a new line of pectin-based cannabis edibles, now exclusively available at Ethos dispensaries across Pennsylvania. This innovative product is the first developed under Ethos’ research collaboration with Sidney Kimmel Medical College at Thomas Jefferson University, marking a significant milestone in the company’s mission to combine cannabis education with wellness solutions.
The Huny Ratio Troches offer three distinct flavors and cannabinoid blends, each designed to support daily wellness routines while maintaining an enjoyable experience. These fruit juice-infused troches are priced at $30 or less and feature the following blends:
- Berry Blend – 1THC:1CBN
- Citrus – 1THC:30CBD
- Strawberry Lemon – 1THC:1CBD
Ethos CEO Gibran Washington emphasized the strategic importance of the launch, stating that the new product not only expands the Huny portfolio but also reinforces Ethos’ goal of providing innovative, research-backed cannabis solutions tailored to meet consumer and patient needs.
Ethos has been collaborating with Thomas Jefferson University since 2020 under a formal Research Agreement, focusing on investigating cannabis’s benefits for medical marijuana patients. “The Ratio Troches reflect our belief that wellness should evolve alongside the demands of daily life,” Washington said. “This product delivers both practicality and quality for patients who seek balance, whether powering through a challenging day or relaxing at night.”
Healthcare professionals, including Dr. Brooke Worster, Associate Professor at Thomas Jefferson University, see the collaboration as a pathway toward broadening the understanding of medical cannabis. Dr. Worster noted the importance of continuous research, particularly in areas such as precise dosing and alternative delivery methods, which products like the troches offer.
Ethos’ focus on Pennsylvania strengthens its leadership in the state’s medical cannabis market, ensuring that patients have access to cutting-edge, science-driven solutions. With a commitment to advancing wellness through innovative formulations, Ethos is shaping the future of medical cannabis by placing research and patient outcomes at the forefront.
This launch signals a forward-looking approach to cannabis as an integral part of holistic wellness. The Huny Ratio Troches’ debut marks not just the enhancement of Ethos’ product portfolio, but a significant step in providing medical cannabis patients with accessible and effective options tailored to their needs.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.